• 3 min read
‘Secure by design’ isn’t just a tech buzzword.

Francis Scialabba
There’s a cybersecurity problem breathing down the healthcare industry’s neck.
On April 7, Baxter Healthcare pulled all 4,100+ Welch Allyn Life2000 ventilators due to severe cybersecurity concerns. The FDA labeled this a Class I recall, meaning these issues threatened patients’ lives, though the agency hasn’t reported any injuries or deaths.
Naomi Schwartz, a former FDA employee and VP of services for MedCrypt, a cybersecurity firm for medical device manufacturers, told Healthcare Brew this recall should be a lesson for the medical technology industry.
This is one of several device recalls in recent years prompted by cybersecurity concerns, and in her opinion, Baxter did the right thing fast. The global medtech company first flagged these weaknesses in November, noting that there hadn’t been any hacks up to that point. An April market removal is a relatively short turnaround, she added.
But the vulnerabilities were easily avoidable with a development framework known as secure by design, the idea that companies—not consumers—are responsible for cybersecurity, and products should have features like multi-factor authentication.
The issues. On a scale of “you have to have a PhD” to “a teenager” could hack the system, Baxter’s ventilator security was more toward the latter, Schwartz said. Let’s run through some of the issues:
Learning opportunities. These issues should prompt other companies to double-check their own ventilators’ security—especially legacy devices that were made many years ago, Schwartz said.
“These are very common problems, and they’re all things that a secure-by-design set of practices would have prevented,” she said.
The good news is Schwartz thinks Baxter responded quickly and appropriately once it discovered these flaws.
“The people out there who are producing and selling these products are doing their due diligence. They’re going back and checking older systems. They’re making sure that things are good and secure, and when they’re not, they’re taking appropriate action,” she said.
This incident comes after the FDA and Congress have ramped up medical device cybersecurity requirements in recent years.
For instance, in March 2023, the Protecting and Transforming Cyber Healthcare Act started requiring medical device manufacturers to address cybersecurity requirements in their submissions for market approval.